York's Dinan Ackman's Latest Investor Enemy

Mar 11 2013 | 10:52am ET

Pershing Square Capital Management's William Ackman has a new peer-adversary.

Already sparring with longtime nemesis Carl Icahn over nutritional supplements company Herbalife—which Ackman calls a "pyramid scheme" and Icahn an opportunity—Ackman now finds himself opposing York Capital Management's James Dinan on retailer JC Penney Corp.

In an inversion of the Herbalife situation, Ackman is extremely bullish on Penney, while Dinan said last week that York is shorting the company's debt. He also gently criticized Ackman and other activists, noting that activism "works great when the tide is rising." But he said that Ackman faces trouble, given Vornado Realty Trust's recent sale of half of its Penney stake, Reuters reports.

Ackman has been investing in Penney since 2010. The retailer's stock price has been falling, and its CEO, former Apple Inc. executive Ron Johnson, was recently forced to abandon his signature program at Penney, an end to sales.

Pershing Square is currently nursing a loss on its Penney holdings.


In Depth

The Benefits Of Private Debt Investing

May 7 2015 | 10:43am ET

Jeffrey Haas is chief operating officer of Old Hill Partners Inc., an SEC-registered...

Lifestyle

Yale Receives $150 Million Gift from Blackstone’s Schwarzman

May 12 2015 | 12:10am ET

Yale University announced it has received a $150 million gift from Blackstone Group...

Guest Contributor

How To Generate 6% Yield In A Volatile World

May 22 2015 | 6:41am ET

Private credit comes in many different flavors, all with the common themes of over...

 

Sponsored Content

Editor's Note